TMO
TMO
Indicative, may be delayed. Not trading-grade data.
Recently viewed
Only on this browser · up to 5Ticker detail
TMO
Cached quote, historical USD prices, and attributed headlines.
AI-generated
AI overview
Latest TMO headlines
- Thermo Fisher Scientific stock fair value rose following a Q3 earnings beat and higher guidance [1][2]. - Market reports mention Thermo Fisher among companies in HPV genotyping, clinical genomics interpretation platforms, and RNA interference technology sectors [3][4][5].
Generated Nov 01, 2026 · 11:43 UTC
- Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q3 Beat And Higher Guidance — Yahoo Finance
- How Investors Are Reacting To Thermo Fisher Scientific Stock After Strong Q3 Earnings — Yahoo Finance
- Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN — Yahoo Finance
- Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI — Yahoo Finance
- Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche — Yahoo Finance
Summary of the linked headlines, not full-article analysis. AI can make mistakes; verify the sources. Not investment advice.
Some history or news is missing or stale. Available cached data remains visible; background requests respect provider retry backoff. Reload this range to check again.
Historical price
23 observations · USD · Source: Yahoo Finance · Sep 30, 2026 · 13:30 UTC to Oct 30, 2026 · 13:30 UTC · latest observation may be incomplete.
News about TMO
- Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q3 Beat And Higher Guidance ↗
- How Investors Are Reacting To Thermo Fisher Scientific Stock After Strong Q3 Earnings ↗
- Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN ↗
- Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI ↗
- Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche ↗
- Clinical Genomics Sequencing, Biobank, and Database Services Global Market to 2035 | Capitalize on AI and Precision Medicine: Illumina, Thermo Fisher, BGI Genomics, Tempus AI ↗
- Global CRISPR Fluorescence Assays Market Report 2026 | Capitalize on 19.5% CAGR to 2030 with Thermo Fisher, Merck, QIAGEN, and Mammoth Biosciences Driving Multiplex Diagnostics ↗
- Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina ↗
- Global Gene Panel Reconciliation Services Market Report 2026 | Capitalize on AI-Driven Genomics as Roche, Thermo Fisher, Illumina and QIAGEN Accelerate a $2.38B Market by 2030 ↗
- Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised Guidance ↗
- 2 cash-producing stocks with promising prospects and 1 we avoid ↗
- RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs ↗
- IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings? ↗
- Repligen Soars 5% as RBC Raises Price Target to $200 After Full-Year Guidance Hike ↗
- Global Reverse Transcription Kits Market Report 2026 | Capitalize on 8.4% CAGR as Roche, Thermo Fisher, Merck, QIAGEN and Promega Accelerate Automation and NGS ↗
- Global Bead-Linked Transposase Library Kits Market Report 2026 | Capitalize on 11.6% CAGR Through 2030 as Illumina, Thermo Fisher, Roche, and Agilent Scale AI-Automated Sequencing ↗
- Synthetic Gene Circuits Global Market Report 2026-2030: Trends and Forecast | Capitalize on 18.1% CAGR and AI-Driven Design with Thermo Fisher, GenScript, and Ginkgo Bioworks ↗
- Global Viral Genome Sequencing Market 2026: Size, Trends, Forecast to 2030 | Capitalize on AI and Real-Time Monitoring with Illumina, Thermo Fisher, Oxford Nanopore, and PacBio ↗
- Molecular Spectroscopy - Global Strategic Business Report: Capitalize on the Surge to $8.7 Billion by 2032 as Agilent, Bruker, Danaher, and Thermo Fisher Scientific Accelerate AI-Driven Analysis ↗
- Metagenome-Assembled Genomes (MAGs) Services Global Market Report 2026 | Capitalize on 15.9% CAGR Through 2030 with AI and Long-Read Sequencing: Thermo Fisher, QIAGEN, BGI Genomics ↗
Comments and bookmarks
Comments are plain text from NPDev accounts. Bookmarks stay private to the account that saved them.
No comments yet. Be the first to say something.
Sign in to join the conversation.